NCT04650490View on ClinicalTrials.gov

SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Brain MetastasesNon Small Cell Lung Cancer
Interventions
RADIATION

Stereotactic Radiosurgery

Timing of stereotactic radiosurgery relative to immunotherapy

DRUG

Immunotherapy

Physician's choice of immunotherapy per standard of care

Trial Locations (1)

27710

Duke Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER